Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin

Endocrinology

Volumn 141, Issue 5, 2000, Pages 1905-1908

  Jones, Kristian L ^a   Brauman, Julie N ^a   Groome, Nigel P ^b   De Kretser, David M ^a   Phillips, David J ^a  

^a MONASH UNIVERSITY   (Australia)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; FOLLISTATIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CIRCULATION; CONTROLLED STUDY; FEMALE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SHEEP;

EID: 0034457246     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.5.7531     Document Type: Article

References (24)

1. Inflammatory cytokines
2. Activin A and follistatin: Their role in the acute phase reaction and inflammation
3. Tumor necrosis factor and interleukin-1 induce activin A gene expression in a human bone marrow stromal cell line
4. Regulation of production of activin A in human marrow stromal cells and monocytes
5. Contrasting effects of inflammatory cytokines and glucocorticoids on the production of activin A in human marrow stromal cells and their implications
6. Regulation of activin-A production by human amnion, decidua and placenta in vitro by pro-inflammatory cytokines
7. The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11. Identification as a stroma-derived activin A
8. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies
9. Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2
10. Divergent cell-specific effects of activin-A on thymocyte proliferation stimulated by phytohemagglutinin, and interleukin-1β or interleukin-6 in vitro
11. Activin A: A novel player and inflammatory marker in inflammatory bowel disease?
12. Serum follistatin concentrations are increased in patients with septicaemia
13. Plasma follistatin concentrations increase following lipopolysaccharide administration in sheep
14. Follistatin concentrations in male sheep increase following sham castration/castration or injection of interleukin-1β
15. Follistatin has a biphasic response but follicle-stimulating hormone is unchanged during an inflammatory episode in growing lambs
16. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid
17. Characterisation of monoclonal antibodies to ovine interleukin-6 and the development of a sensitive capture ELISA
18. Temporal profiles of interleukin-1β, interleukin-6, and tumor necrosis factor-α in the plasma and hypothalamic paraventricular nucleus after intravenous or intraperitoneal administration of lipopolysaccharide in the rat: Estimation by push-pull perfusion
19. Activin A/erythroid differentiation factor is induced during human monocyte activation
20. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A
21. Transforming growth factor-β and its receptors
22. The release of transforming growth factor-β following haemorrhage: Its role as a mediator of host immunosuppression
23. Transforming growth factor-β negatively modulates T-cell responses in sepsis
24. Follistatin: A multifunctional regulatory protein